関連する実験動画

Updated: Jun 14, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K

PD- L1,LAG3,およびVISTAの臨床的重要性

Yun Ji Lee1, Jin Ho Baek1, Jong Gwang Kim1

  • 1Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Kyungpook National University Cancer Research Institute, Daegu, Republic of Korea.

Anticancer research
|August 28, 2025
PubMed
まとめ

免疫マーカーであるVドメインのT細胞活性化抑制剤 (VISTA) とリンパ球活性化遺伝子3 (LAG3) は,凝固性の低い細胞の胃がん (PCC-GC) の予後指標となる可能性がある. 免疫細胞 (ICs) でのVISTAの高発は,ステージIIIの疾患と好ましい結果と関連しています.

キーワード:
LAG3 についてPCC-GC についてPD-L1 についてVISTAについて予後バイオマーカー

さらに関連する動画

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.7K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.7K

関連する概念動画

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.